BioDelivery Sciences International Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
59.35 M |
Public Float |
51.87 M |
BioDelivery Sciences International Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.6 |
Market Cap |
$413.56 M |
Shares Outstanding |
89.43 M |
Public Float |
65.12 M |
Address |
4131 ParkLake Avenue Raleigh North Carolina 27612 United States |
Employees | - |
Website | http://www.bdsi.com |
Updated | 07/08/2019 |
BioDelivery Sciences International, Inc. is a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. |